Under way, not recruiting
Cryodevitalization for the Treatment of Early Stage Lung Cancer, CRYSTAL Trial
NCT06593106 · Vanderbilt-Ingram Cancer Center · Updated 18 Aug 2026
- What is being tested
- Cryosurgery; Robotic Bronchoscopy; Bronchoscopy with Biopsy; Resection; Chest Radiography; Computed Tomography; Biospecimen Collection; Electronic Health Record Review
- For
- Stage I Lung Cancer; Stage II Lung Cancer
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 13 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started 27 Sept 2024, ends 31 Aug 2027. Registered 19 Sept 2024.
- Results
- None posted yet.
In the researchers' words
This clinical trial studies side effects and best treatment time of cryodevitalization in treating patients with early stage (stage I or stage II) lung cancer. Cryodevitalization is a type of cryosurgery that uses a flexible probe (cryoprobe) to kill tumor cells by freezing them. It is delivered at the time of standard diagnostic robotic bronchoscopy. Using cryodevitalization may be safe, tolerable and/or effective in treating patients with early stage lung cancer.
Sites
- Vanderbilt University/Ingram Cancer CenterNashville, Tennessee, United States